Global Low Molecular Weight Heparin Market Research Report 2012-2024

Publisher Name :
Date: 19-Jul-2019
No. of pages: 82

Summary

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

The global Low Molecular Weight Heparin market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

- Enoxaparin

- Dalteparin

- Tinzaparin

- Fraxiparine

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

- Aspen

- Sanofi-aventis

- Pfizer

- Opocrin

- CSBIO

- Dongying Tiandong Pharmaceutical

- Changzhou Qianhong Bio-pharma

- Techdow

- Yantai Dongcheng Pharmaceutical Group

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

- Treatment of Venous Thromboembolism

- Complications of Pregnancy

- Cardioversion of Atrial Fibrillation/Flutter

- Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

- Asia-Pacific

- North America

- Europe

- South America

- Middle East & Africa

Global Low Molecular Weight Heparin Market Research Report 2012-2024

Table of Contents

1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Enoxaparin
1.2.1.2 Dalteparin
1.2.1.3 Tinzaparin
1.2.1.4 Fraxiparine
1.2.2 by Application
1.2.2.1 Treatment of Venous Thromboembolism
1.2.2.2 Complications of Pregnancy
1.2.2.3 Cardioversion of Atrial Fibrillation/Flutter
1.2.2.4 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Enoxaparin Market, 2013-2018
4.1.2 Dalteparin Market, 2013-2018
4.1.3 Tinzaparin Market, 2013-2018
4.1.4 Fraxiparine Market, 2013-2018
4.2 Market Forecast
4.2.1 Enoxaparin Market Forecast, 2019-2024
4.2.2 Dalteparin Market Forecast, 2019-2024
4.2.3 Tinzaparin Market Forecast, 2019-2024
4.2.4 Fraxiparine Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Treatment of Venous Thromboembolism Market, 2013-2018
5.1.2 Complications of Pregnancy Market, 2013-2018
5.1.3 Cardioversion of Atrial Fibrillation/Flutter Market, 2013-2018
5.1.4 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Treatment of Venous Thromboembolism Market Forecast, 2019-2024
5.2.2 Complications of Pregnancy Market Forecast, 2019-2024
5.2.3 Cardioversion of Atrial Fibrillation/Flutter Market Forecast, 2019-2024
5.2.4 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Aspen
8.2 Sanofi-aventis
8.3 Pfizer
8.4 Opocrin
8.5 CSBIO
8.6 Dongying Tiandong Pharmaceutical
8.7 Changzhou Qianhong Bio-pharma
8.8 Techdow
8.9 Yantai Dongcheng Pharmaceutical Group
9 Conclusion

List of Tables

Table Product Specifications of Low Molecular Weight Heparin
Table Products Segment of Low Molecular Weight Heparin
Table Enoxaparin Overview
Table Dalteparin Overview
Table Tinzaparin Overview
Table Fraxiparine Overview
Table Global Low Molecular Weight Heparin Market by Type, 2011-2022 (USD Million)
Table Application Segment of Low Molecular Weight Heparin
Table Treatment of Venous Thromboembolism Overview
Table Complications of Pregnancy Overview
Table Cardioversion of Atrial Fibrillation/Flutter Overview
Table Others Overview
Table Global Low Molecular Weight Heparin Market by Application, 2011-2022 (USD Million)
Table Global Low Molecular Weight Heparin Market by Region, 2011-2022 (USD Million)
Table Cost of Low Molecular Weight Heparin
Table Market Dynamics
Table Policy of Low Molecular Weight Heparin
Table GDP of Major Countries
Table Enoxaparin CAGR by Revenue and Volume, 2012-2018
Table Dalteparin CAGR by Revenue and Volume, 2012-2018
Table Tinzaparin CAGR by Revenue and Volume, 2012-2018
Table Fraxiparine CAGR by Revenue and Volume, 2012-2018
Table Enoxaparin CAGR by Revenue and Volume, 2012-2024
Table Dalteparin CAGR by Revenue and Volume, 2012-2024
Table Tinzaparin CAGR by Revenue and Volume, 2012-2024
Table Fraxiparine CAGR by Revenue and Volume, 2012-2024
Table Treatment of Venous Thromboembolism CAGR by Revenue and Volume, 2012-2018
Table Complications of Pregnancy CAGR by Revenue and Volume, 2012-2018
Table Cardioversion of Atrial Fibrillation/Flutter CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Low Molecular Weight Heparin Market by Vendors, 2012-2018 (USD Million)
Table Global Low Molecular Weight Heparin Market by Vendors, 2012-2018 (in Volume)
Table Global Low Molecular Weight Heparin Market Share by Vendors, 2012-2018 (USD Million)
Table Global Low Molecular Weight Heparin Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Aspen Profile List
Table Microecological Modulator Operating Data of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-aventis Profile List
Table Microecological Modulator Operating Data of Sanofi-aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Opocrin Profile List
Table Microecological Modulator Operating Data of Opocrin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSBIO Profile List
Table Microecological Modulator Operating Data of CSBIO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dongying Tiandong Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Dongying Tiandong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changzhou Qianhong Bio-pharma Profile List
Table Microecological Modulator Operating Data of Changzhou Qianhong Bio-pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Techdow Profile List
Table Microecological Modulator Operating Data of Techdow (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Yantai Dongcheng Pharmaceutical Group Profile List
Table Microecological Modulator Operating Data of Yantai Dongcheng Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List of Figures

Figure Low Molecular Weight Heparin Picture
Figure Industry Chain Structure of Low Molecular Weight Heparin
Figure SWOT of Low Molecular Weight Heparin
Figure Enoxaparin Market Size and Growth, 2012-2018 (USD Million)
Figure Enoxaparin Market Size and Growth, 2012-2018 (in Volume)
Figure Dalteparin Market Size and Growth, 2012-2018 (USD Million)
Figure Dalteparin Market Size and Growth, 2012-2018 (in Volume)
Figure Tinzaparin Market Size and Growth, 2012-2018 (USD Million)
Figure Tinzaparin Market Size and Growth, 2012-2018 (in Volume)
Figure Fraxiparine Market Size and Growth, 2012-2018 (USD Million)
Figure Fraxiparine Market Size and Growth, 2012-2018 (in Volume)
Figure Enoxaparin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Enoxaparin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Dalteparin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Dalteparin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Tinzaparin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Tinzaparin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Fraxiparine Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Fraxiparine Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Treatment of Venous Thromboembolism Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Complications of Pregnancy Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cardioversion of Atrial Fibrillation/Flutter Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Low Molecular Weight Heparin Market Concentration by Region
Figure Marketing Channels Overview
  • COVID-19 Outbreak-Global Hemophilia Treatment Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 07-Jul-2020        Price: US 3660 Onwards        Pages: 108
    Hemophilia is a rare disorder in which patient‘s blood doesn't clot normally because it lacks sufficient blood-clotting proteins (clotting factors). If patients have hemophilia, they may bleed for a longer time after an injury than patient would if your blood clotted normally. Several different types of clotting factors are associated with different varieties of hemophilia. The main treatment for severe hemophilia involves receiving replacement of the specific clotting factor that you need, thro......
  • Factor VIII Inhibitor - Pipeline Insight, 2020
    Published: 03-Jul-2020        Price: US 1500 Onwards        Pages: 60
    Overview "Factor VIII Inhibitor - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Factor VIII Inhibitor pipeline landscape is provided, which includes the topic Overview and Factor VIII Inhibitor mechanism of action. The assessment part of the report embraces, in-depth Factor VIII Inhibitor commercial assessment and clinical assessment of the pipe......
  • Global Thrombin (Human) Market Insights and Forecast to 2026
    Published: 02-Jul-2020        Price: US 3900 Onwards        Pages: 113
    Thrombin (Human) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Thrombin (Human) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Thrombin (Human) market is segmented into - 500IU/Vial - 1000IU/Vial - 2500IU/Vial ......
  • COVID-19 Outbreak-Global Fibrinogen Concentrates Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 30-Jun-2020        Price: US 3660 Onwards        Pages: 110
    Fibrinogen, also known as coagulation factor I, is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen deficiency is a rare bleeding disorder characterized by mild to severe form of bleeding. The three types for fibrinogen deficiencies are: afibrinogenemia, hypofibrogenemia, and dysfibrinogenemia. In severely bleeding patients, fibrinogen concentrate significantly improves whole blood clot firmness and reduces the postoperative transfusion requirements. Currently......
  • COVID-19 Outbreak-Global Low Molecular Weight Heparin Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 28-Jun-2020        Price: US 3660 Onwards        Pages: 111
    Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.The Low Molecular Weight Heparin market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of ......
  • COVID-19 Outbreak-Global Intravenous Immunoglobulin (Ivig) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 28-Jun-2020        Price: US 3660 Onwards        Pages: 128
    The Intravenous Immunoglobulin (Ivig) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise pro......
  • Hemophilia Treatment Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 26-Jun-2020        Price: US 2280 Onwards        Pages: 58
    Summary According to 99Strategy, the Global Hemophilia Treatment Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Hemophilia Treatment market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report......
  • Global Hemophilia Drugs Market Research Report 2020 (Covid-19 Version)
    Published: 24-Jun-2020        Price: US 3500 Onwards        Pages: 162
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Hemophilia A - Hemophilia B - Hemophilia C By Application - Clinic - Hospital By Company - Baxalta - Bayer - CSL Behring - Novo Nordisk - Pfizer - Roche - Alnylam Pharmaceuticals......
  • Heparin Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 22-Jun-2020        Price: US 2280 Onwards        Pages: 52
    Summary According to 99Strategy, the Global Heparin Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Heparin market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driv......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs